YLR163W-A is a non-essential gene in Saccharomyces cerevisiae (budding yeast) located on chromosome XII. It is classified as a "questionable ORF" with limited functional characterization. Key features include:
| Feature | Details |
|---|---|
| Genomic Coordinates | Chromosome XII: 255,567–256,079 (S288C reference genome) |
| Protein Length | 170 amino acids |
| Molecular Weight | ~19.8 kDa |
| Isoelectric Point | Predicted pI: 4.85 |
| Conservation | No orthologs identified in other species |
No experimentally determined protein abundance or functional data (e.g., phenotypes, interactions) are available for this locus .
While the provided sources extensively discuss antibodies (e.g., structure, therapeutic applications, and research techniques ), none mention an antibody targeting YLR163W-A.
Key antibody-related findings from the search results include:
Structural Features: Antibodies are Y-shaped proteins with Fab (antigen-binding) and Fc (effector function) regions .
Therapeutic Applications: Monoclonal antibodies target biomarkers like TNF-α, IL-17, and HER2 for diseases such as cancer and autoimmune disorders .
Research Techniques: Antibodies are used in ELISA, Western blot, and flow cytometry for protein detection and quantification .
Gene Characterization: YLR163W-A is poorly characterized, with no known associated protein function or disease relevance in yeast or humans.
Antibody Development: Antibodies are typically developed against proteins with established biological roles. The lack of functional data for YLR163W-A makes it an unlikely target for antibody production.
Nomenclature Confusion: The term "YLR163W-A Antibody" may conflate the gene name (YLR163W-A) with unrelated antibody research (e.g., CA125/MUC16 antibodies or SARS-CoV-2 neutralizing antibodies ).
To investigate YLR163W-A further:
Functional Studies: Perform knock-out experiments to assess phenotypic effects in yeast.
Protein Characterization: Use mass spectrometry or immunoprecipitation to identify interacting partners.
Antibody Generation: Develop custom polyclonal/monoclonal antibodies if the protein is confirmed to have research or clinical relevance .
YLR163W-A is an uncharacterized protein from Saccharomyces cerevisiae (strain S288c/Baker's yeast), which serves as an important model organism in molecular and cellular biology research. The protein is encoded by the YLR163W-A gene locus in the yeast genome. While its function remains largely uncharacterized, studying this protein contributes to our understanding of yeast proteome and potentially reveals novel cellular mechanisms. Antibodies against this protein serve as valuable tools for detecting, quantifying, and characterizing its expression, localization, and interactions in various experimental contexts. The significance lies in expanding our knowledge of the yeast proteome, which serves as a foundation for understanding eukaryotic cell biology more broadly .
YLR163W-A antibodies can be applied in several experimental techniques:
Western Blot (WB): For detecting and quantifying YLR163W-A protein in cell or tissue lysates, allowing analysis of protein expression levels across different experimental conditions.
Enzyme-Linked Immunosorbent Assay (ELISA): For quantitative detection of YLR163W-A in solution.
Immunoprecipitation (IP): For isolating YLR163W-A and its binding partners to study protein-protein interactions.
Immunofluorescence (IF): For visualizing subcellular localization of YLR163W-A in fixed yeast cells.
Chromatin Immunoprecipitation (ChIP): If YLR163W-A has any DNA-binding capacity, ChIP can be used to identify its genomic binding sites .
When designing experiments, researchers should validate antibody specificity using appropriate controls, including wild-type versus knockout strains, when possible.
Sample preparation for YLR163W-A detection requires careful consideration of yeast cell lysis conditions:
Cell lysis buffer selection: Use buffers containing 50mM Tris-HCl (pH 7.5), 150mM NaCl, 1% Nonidet P-40, and protease inhibitor cocktail. For membrane-associated proteins, consider adding 0.5% sodium deoxycholate.
Mechanical disruption methods:
Glass bead lysis: Most effective for yeast cells when combined with vortexing
Enzymatic cell wall digestion: Using lyticase or zymolyase before gentle detergent lysis
Freeze-thaw cycles: Useful for preserving protein complexes
Protein denaturation conditions: For Western blot applications, samples should be denatured in Laemmli buffer at 95°C for 5 minutes, though some experiments may require non-denaturing conditions to preserve protein structure.
Protein concentration determination: Bradford or BCA assays should be used to normalize protein loading.
For microscopy applications, fixation with 4% paraformaldehyde followed by spheroplasting is generally recommended to maintain cellular architecture while allowing antibody penetration.
Proper experimental controls are essential for validating results with YLR163W-A antibody:
| Control Type | Purpose | Implementation |
|---|---|---|
| Positive Control | Confirm antibody functionality | Use recombinant YLR163W-A protein or extract from cells known to express the protein |
| Negative Control | Assess non-specific binding | Use extract from YLR163W-A knockout strain |
| Loading Control | Ensure equal protein loading | Detect housekeeping proteins (e.g., GAPDH, actin) |
| Isotype Control | Evaluate background binding | Use non-specific IgG of same isotype and concentration |
| Peptide Competition | Verify antibody specificity | Pre-incubate antibody with excess purified antigen before application |
| Secondary Antibody Only | Detect non-specific binding | Omit primary antibody while including secondary antibody |
These controls help distinguish genuine signals from artifacts and are particularly important for uncharacterized proteins like YLR163W-A where reference data may be limited .
Optimizing signal-to-noise ratio for YLR163W-A antibody applications involves multiple strategies:
Antibody titration: Perform systematic dilution series (typically 1:500 to 1:5000) to identify the optimal concentration that maximizes specific signal while minimizing background. Document signal intensity versus antibody concentration.
Blocking optimization:
Test multiple blocking agents: BSA (1-5%), non-fat dry milk (1-5%), casein, commercial blocking buffers
Evaluate different blocking durations: 30 minutes to overnight at 4°C
Consider adding 0.1-0.3% Triton X-100 or Tween-20 to reduce hydrophobic interactions
Extraction condition modification: For membrane or nuclear proteins, test different detergent combinations (CHAPS, digitonin, DDM) at varying concentrations.
Signal amplification systems:
Biotin-streptavidin systems
Tyramide signal amplification
Polymer-based detection systems
Instrumentation optimization:
For fluorescence applications, adjust exposure settings and utilize spectral unmixing
For chemiluminescence, optimize exposure time through multiple test exposures
Systematic recording of optimization experiments in a standardized format allows for reproducible protocols across different batches of samples .
Cross-reactivity is a significant concern when working with antibodies against uncharacterized proteins:
Potential cross-reactivity sources:
Homologous proteins in yeast (paralogs)
Proteins with similar epitope structures
Highly abundant proteins that generate background binding
Cross-reactivity assessment methods:
Western blot analysis using YLR163W-A knockout strain
Mass spectrometry identification of immunoprecipitated proteins
Epitope mapping to identify potential cross-reactive regions
Preabsorption with recombinant protein to confirm specificity
Mitigation strategies:
Affinity purification of polyclonal antibodies against the specific antigen
Using monoclonal antibodies that recognize unique epitopes
Implementing stringent washing conditions in immunoassays
Pre-clearing lysates with non-specific IgG before immunoprecipitation
Validation across techniques:
Confirm results using orthogonal detection methods
Verify protein identity using mass spectrometry following immunoprecipitation
Cross-reactivity assessment is particularly important for antibodies against uncharacterized proteins where functional redundancy with other proteins might exist .
Integration of YLR163W-A antibody studies with multi-omics approaches enables comprehensive protein characterization:
Proteomics integration:
Immunoprecipitation followed by mass spectrometry (IP-MS) to identify protein interaction partners
Correlation of antibody-based quantification with label-free or isotope-labeled quantitative proteomics
Validation of post-translational modifications identified in large-scale proteomic studies
Transcriptomics correlation:
Analysis of YLR163W-A protein expression in relation to mRNA levels across conditions
Investigation of potential post-transcriptional regulation mechanisms
Development of integrated expression profiles across environmental conditions
Functional genomics linkage:
Phenotypic analysis of YLR163W-A knockout or overexpression strains
Correlation with genetic interaction networks from large-scale screens
Systematic analysis across stress conditions to identify functional contexts
Data integration framework:
Utilization of gene ontology enrichment for interacting partners
Network analysis incorporating protein-protein interaction databases
Pathway mapping of YLR163W-A and associated proteins
Visualization tools:
Construction of integrated heatmaps showing protein expression, genetic interactions, and phenotypic data
Protein localization data integrated with interaction networks
Successful integration requires careful normalization of data from different platforms and consideration of the temporal dynamics of different molecular events .
When faced with contradictory results in YLR163W-A antibody experiments, a systematic troubleshooting approach is necessary:
When presenting contradictory results, transparent reporting of all experimental conditions and analytical decisions is essential for scientific progress .
Computational methods significantly enhance the interpretation of YLR163W-A antibody experimental data:
Image analysis for microscopy data:
Automated cell segmentation for quantification of subcellular localization
Colocalization analysis with known organelle markers
Single-cell quantification of protein expression heterogeneity
Time-lapse analysis for dynamic protein behavior
Quantitative analysis of immunoblots:
Densitometry standardization across experimental replicates
Implementation of local background subtraction methods
Statistical comparison across multiple conditions with appropriate tests
Normalization strategies for loading variations
Machine learning applications:
Pattern recognition in complex localization or expression datasets
Classification of phenotypes in knockout/knockdown experiments
Prediction of protein-protein interactions based on co-immunoprecipitation data
Integration of antibody-based data with public database information
Systems biology modeling:
Network inference incorporating YLR163W-A interactions
Pathway enrichment analysis for functional contextualization
Prediction of protein function based on interaction partners
Evolutionary analysis of protein conservation and divergence
Active learning approaches:
Iterative experimental design optimization based on machine learning models
Reduction of required experiments through intelligent sampling strategies
Improvement of out-of-distribution predictions for antibody-antigen interactions
Acceleration of binding prediction through optimized library-on-library approaches
The integration of computational approaches with antibody-based experimental data can reveal patterns and relationships not apparent through traditional analysis methods.
Proper storage and handling of YLR163W-A antibodies is crucial for maintaining activity and specificity:
Storage temperature guidelines:
Long-term storage: -80°C in small aliquots to avoid repeated freeze-thaw cycles
Medium-term storage: -20°C with glycerol or suitable cryoprotectant
Working stocks: 4°C for up to 2 weeks, depending on antibody stability
Buffer composition considerations:
PBS or TBS base buffer with pH 7.2-7.6
Addition of 0.02% sodium azide as preservative
For polyclonal antibodies: Addition of 50% glycerol for freeze protection
For certain applications: Addition of carrier proteins (BSA 1-5mg/ml)
Stability assessment protocol:
Periodic testing against standard controls
Monitoring antibody performance with consistent positive controls
Documentation of signal intensity across storage time
Handling precautions:
Minimize exposure to light for fluorophore-conjugated antibodies
Avoid repeated freeze-thaw cycles (maximum 5 recommended)
Use screw-cap microcentrifuge tubes to prevent evaporation
Centrifuge briefly before opening to collect solution
Reconstitution guidelines (for lyophilized antibodies):
Use sterile ddH₂O or recommended buffer
Allow complete solubilization at room temperature
Gentle mixing without vortexing to prevent denaturation
Implementing a quality control system with regular antibody validation checks ensures experimental reproducibility over time .
Developing standardized protocols for YLR163W-A detection requires careful attention to multiple experimental parameters:
Standardization components:
Detailed documentation of all reagents (catalog numbers, lot numbers)
Preparation of master mixes where possible to reduce pipetting variations
Inclusion of consistent positive and negative controls across experiments
Implementation of calibration standards for quantitative applications
Key parameters to control and document:
| Parameter | Standardization Approach | Documentation Requirements |
|---|---|---|
| Antibody concentration | Titration to optimal signal:noise | Lot number, dilution, diluent composition |
| Incubation conditions | Time, temperature, agitation method | Exact timing, equipment settings |
| Washing steps | Buffer composition, volume, duration | Number of washes, volumes, timing |
| Detection system | Reagent preparation, exposure settings | Lot numbers, equipment settings, gain values |
| Sample preparation | Lysis method, protein quantification | Cell density, buffer composition, storage conditions |
Protocol validation process:
Inter-operator reproducibility testing
Cross-instrument validation where applicable
Statistical analysis of technical variability
Development of acceptance criteria based on control performance
Standard operating procedure (SOP) format:
Step-by-step instructions with timing
Decision trees for troubleshooting
Expected results with representative images
Quality control checkpoints throughout protocol
Data management standards:
Consistent file naming conventions
Raw data preservation guidelines
Analysis pipeline documentation
Results reporting templates
Implementing electronic laboratory notebooks with protocol versioning ensures experimental reproducibility and facilitates troubleshooting when variations occur .
Advanced techniques for studying YLR163W-A protein interactions and dynamics provide deeper insights beyond standard antibody applications:
Proximity-based interaction methods:
Proximity Ligation Assay (PLA) for detecting protein-protein interactions in situ
BioID or TurboID proximity labeling to identify neighboring proteins
FRET/BRET approaches using fluorescent protein fusions
Split complementation systems (BiFC, split luciferase) for interaction validation
Live-cell dynamics techniques:
Fluorescence Recovery After Photobleaching (FRAP) for mobility analysis
Single-molecule tracking with photoactivatable fluorescent proteins
Optogenetic control of protein localization and interactions
Fast time-resolution imaging with lattice light-sheet microscopy
Structural biology approaches:
Hydrogen-deuterium exchange mass spectrometry for interaction surfaces
Cross-linking mass spectrometry for interface mapping
Cryo-electron microscopy of complexes containing YLR163W-A
NMR analysis of purified protein domains and complexes
Quantitative interaction proteomics:
SILAC or TMT labeling for differential interactome analysis
Correlation profiling across biochemical fractionations
Thermal proteome profiling to assess complex stability
Absolute quantification of stoichiometry in complexes
Genome engineering approaches:
Endogenous tagging with split reporters for interaction mapping
Knock-in of fluorescent tags at the genomic locus
Anchor-Away or degron systems for rapid depletion studies
CRISPR interference/activation for expression modulation
These advanced techniques can be integrated with standard antibody-based approaches to create a comprehensive understanding of YLR163W-A function and interactions .
Experimental design considerations:
Power analysis to determine appropriate sample size
Randomization strategies to minimize batch effects
Blinding procedures for unbiased analysis
Inclusion of biological and technical replicates
Normalization strategies:
Internal reference genes/proteins for expression normalization
Total protein normalization (e.g., Ponceau S, Stain-Free technology)
Spike-in controls for absolute quantification
Batch correction methods for multi-experiment integration
Statistical test selection:
| Data Type | Appropriate Tests | Assumptions | Multiple Testing Correction |
|---|---|---|---|
| Two-group comparison | t-test, Mann-Whitney | Normality (for t-test) | Bonferroni, Benjamini-Hochberg |
| Multi-group comparison | ANOVA, Kruskal-Wallis | Homogeneity of variance | Tukey HSD, Dunn's test |
| Correlation analysis | Pearson, Spearman | Linearity, distribution | N/A |
| Time course | Repeated measures ANOVA, mixed models | Sphericity, missing data handling | Post-hoc specific comparisons |
Visualization best practices:
Scatter plots showing individual data points alongside means/medians
Box plots displaying distribution characteristics
Visualization of effect sizes with confidence intervals
Consistent y-axis scaling to avoid visual distortion
Reporting guidelines:
Clear statement of statistical methods with justification
Exact p-values rather than significance thresholds
Confidence intervals for effect size estimates
Transparent reporting of outlier handling and exclusion criteria
Implementing a standardized data analysis pipeline with documentation of all statistical decisions enhances reproducibility and facilitates meta-analysis across studies .
Interpreting YLR163W-A localization studies requires careful consideration of multiple factors:
Fixation method effects:
Paraformaldehyde: Good structure preservation but may mask some epitopes
Methanol: Better for certain epitopes but disrupts membrane structures
Glutaraldehyde: Strong fixation but higher autofluorescence
Comparison of results across fixation methods for validation
Resolution considerations:
Diffraction-limited confocal: ~200-250 nm lateral resolution
Super-resolution techniques: Improved resolution to 20-100 nm
Electron microscopy correlation: Nanometer-scale localization with immunogold
Impact of resolution on interpretation of colocalization data
Colocalization analysis:
Quantitative colocalization metrics (Pearson's, Manders' coefficients)
Point spread function considerations in optical microscopy
3D reconstruction for volumetric colocalization assessment
Statistical significance testing for colocalization coefficients
Dynamics interpretation:
Cell cycle phase considerations
Response to environmental conditions or stress
Temporal dynamics during developmental processes
Protein mobility assessment through photobleaching recovery
Common artifacts and controls:
Fixation-induced protein redistribution
Antibody accessibility limitations in dense structures
Background autofluorescence from metabolites
Use of tagged proteins as complementary approach
Quantification approaches:
Intensity-based measurements across subcellular regions
Object-based analysis of punctate structures
Population heterogeneity assessment
Correlation with functional assays for biological validation
Integration of localization data with functional studies provides context for interpreting the significance of YLR163W-A subcellular distribution .
Building a comprehensive model of YLR163W-A function requires systematic integration of data from multiple experimental approaches:
Multi-technique triangulation strategy:
Biochemical approaches: Purification, enzymatic assays, binding studies
Cell biology techniques: Localization, trafficking, stress response
Genetic methods: Knockout phenotypes, synthetic interactions
Structural biology: Domain architecture, interaction surfaces
Systems approaches: Network context, pathway involvement
Hierarchical data integration framework:
Primary structure and modifications (sequence, PTMs)
Secondary/tertiary structure (domains, folding)
Quaternary structure (complexes, oligomerization)
Subcellular localization and trafficking
Physiological function and regulation
Computational modeling approaches:
Homology-based function prediction
Molecular dynamics simulations
Network-based function inference
Evolutionary analysis for functional constraints
Functional annotation synthesis:
Gene Ontology term assignment with evidence codes
Pathway mapping with confidence scoring
Phenotypic signature analysis across conditions
Disease relevance in higher eukaryotic homologs
Visualization and communication tools:
Integrated data visualization dashboards
Molecular graphics of structural features
Dynamic models of temporal regulation
Accessible summaries for different audience expertise levels
Knowledge gaps identification:
Systematic documentation of contradictory findings
Structured approach to hypothesis generation
Prioritization of experiments to resolve uncertainties
Collaboration strategies for technique specialization
This integrated approach transforms isolated experimental findings into a coherent functional model with clearly indicated confidence levels and remaining uncertainties .
Several emerging technologies promise to transform antibody-based research for proteins like YLR163W-A:
Next-generation antibody technologies:
Nanobodies and single-domain antibodies for improved penetration
DNA-barcoded antibodies for highly multiplexed detection
Recombinant antibody engineering for enhanced specificity
Photoswitchable antibodies for super-resolution applications
Single-cell proteomics integration:
Mass cytometry (CyTOF) for single-cell protein profiling
Microfluidic platforms for antibody-based single-cell analysis
Spatial proteomics with multiplexed antibody imaging
Integration with single-cell transcriptomics for multi-omic profiling
In situ structural analysis:
Proximity labeling with residue-level resolution
Correlative light and electron microscopy with specific labeling
Cryo-electron tomography of cellular structures
4D visualization of protein dynamics in living cells
AI and machine learning applications:
Deep learning for image analysis and pattern recognition
Predictive modeling of protein interactions and functions
Automated experimental design optimization
Natural language processing for literature mining and hypothesis generation
Microproteomic approaches:
Ultrasensitive detection from limited samples
Single-molecule antibody-based detection methods
Nano-immunoprecipitation from subcellular structures
Targeted proteomics with antibody-guided mass spectrometry
These technologies will enable more sensitive, specific, and comprehensive analysis of uncharacterized proteins like YLR163W-A, potentially revealing functions that have remained elusive with current methods .
Strategic design of follow-up studies for YLR163W-A functional characterization:
This strategic approach to follow-up studies maximizes the probability of identifying the biological function of this uncharacterized protein while minimizing experimental bias and artifacts .
YLR163W-A antibody research presents unique challenges and opportunities that shape the field's trajectory:
Current challenges:
Limited functional characterization hampers hypothesis development
Potential cross-reactivity with related proteins requires rigorous validation
Low expression levels may necessitate sensitive detection methods
Reproducibility across different antibody lots and laboratories
Integration of data from various techniques into coherent models
Emerging opportunities:
Application of systems biology approaches for functional prediction
Development of engineered strains for controlled expression
Integration with structural biology for mechanistic insights
Computational modeling to guide experimental design
Comparative studies across model organisms for evolutionary insights
Methodological advancements:
Increased antibody specificity through recombinant approaches
Enhanced sensitivity through signal amplification technologies
Multiplexed detection for contextual protein analysis
Quantitative imaging with improved spatial and temporal resolution
Integration with CRISPR-based genetic manipulation
Collaborative frameworks:
Cross-disciplinary approaches combining expertise
Data sharing initiatives for maximal knowledge extraction
Standardization efforts for improved reproducibility
Open science practices to accelerate discovery
Researchers working with YLR163W-A and similar uncharacterized proteins face the dual challenge of developing reliable experimental methods while simultaneously generating hypotheses about protein function. The field continues to evolve toward integrated approaches that leverage multiple technologies and computational methods to build comprehensive functional models .